|
Participant's country of birth, other specify
|
CANPATH_0000660 |
|
|
Mother's country of birth, other specify
|
CANPATH_0000662 |
|
|
Siblings cancer, other specify
|
CANPATH_0000420 |
|
|
Mother's country of birth
|
CANPATH_0000661 |
|
|
Anatomical Therapeutic Chemical (ATC) code (match) - medication 21
|
CANPATH_0000888 |
|
|
Biological mother has another ethnic background.
|
CANPATH_0000646 |
|
|
Siblings kidney cancer
|
CANPATH_0000404 |
|
|
Brand name of medication from the Drug Product Database (DPD) - medication 21
|
CANPATH_0000887 |
|
|
Biological mother's ethnic background is White (European descent).
|
CANPATH_0000645 |
|
|
Number of siblings with uterine cancer
|
CANPATH_0000403 |
|
|
Biological father's ethnic background is Arab (e.g. Egypt, Iraq, Jordan, Lebanon).
|
CANPATH_0000648 |
|
|
Siblings bladder cancer
|
CANPATH_0000406 |
|
|
Anatomical Therapeutic Chemical (ATC) code - medication 21
|
CANPATH_0000889 |
|
|
Biological father's ethnic background is Aboriginal (e.g. First Nations, Metis, Inuit).
|
CANPATH_0000647 |
|
|
Number of siblings with kidney cancer
|
CANPATH_0000405 |
|
|
Siblings cervical cancer
|
CANPATH_0000400 |
|
|
Drug identification number (DIN) - medication 21
|
CANPATH_0000884 |
|
|
Biological mother's ethnic background is South Asian (e.g. India, Sri Lanka, Pakistan, Bangladesh).
|
CANPATH_0000642 |
|
|
Chemical substance, 5th level of ATC classification - medication 20
|
CANPATH_0000883 |
|
|
Biological mother's ethnic background is Latin American/Hispanic).
|
CANPATH_0000641 |
|
